Evidence map›Paper›PMID 42521912›Full record

ArticleAnnals of surgical oncology2026

Successful Redo Right Hepatic Vein Reconstruction for Recurrent Colorectal Liver Metastases After Triple Hepatic Vein Resection: Implications of Late-Onset Venous Stenosis.

Yui Sawa, Yoshihiro Ono, Gaku Shimane, Tatsunori Hashimoto, Satoshi Tsuchiya, Yozo Sato, Manabu Takamatsu, Sho Kiritani, Kosuke Kobayashi, Hiromichi Ito and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yui SawaDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yoshihiro OnoDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. yoshihiro.ono@jfcr.or.jp.
Gaku ShimaneDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Tatsunori HashimotoDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Satoshi TsuchiyaDepartment of Diagnostic Ultrasound and Interventional Radiology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yozo SatoDepartment of Diagnostic Ultrasound and Interventional Radiology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Manabu TakamatsuDepartment of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Sho KiritaniDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kosuke KobayashiDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Hiromichi ItoDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yosuke InoueDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kiyoshi MatsuedaDepartment of Diagnostic Ultrasound and Interventional Radiology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yu TakahashiDivision of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. yu.takahashi@jfcr.or.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn colorectal liver metastases deemed unresectable, advances in chemotherapy and venous reconstruction techniques have enabled resection in selected patients. PATIENT AND

methodsWe experienced a case of late stenosis in a reconstructed hepatic vein that had remained patent for 8 years. To further investigate this issue, we analyzed the causes and timing of venous stenosis in 72 reconstructed veins from 66 cases performed at our institution between 2004 and 2025.

resultsA 49-year-old woman with initially unresectable rectal cancer and multiple liver metastases involving all three major hepatic veins underwent extended hepatectomy with triple hepatic vein resection and reconstruction after chemotherapy, and 8 years later, severe stenosis of the reconstructed right hepatic vein (RHV) was detected without definitive evidence of recurrence on imaging. Redo RHV resection and reconstruction using a right internal jugular vein graft were performed, and pathological examination confirmed tumor recurrence. Among the 72 reconstructed veins, stenosis occurred in 19, with 14 being due to technical factors unrelated to tumor and 5 associated with tumor recurrence. All technical stenoses occurred within 6 months, while all late stenoses were attributable to tumor recurrence.

conclusionsLate venous stenosis after hepatic vein reconstruction should raise suspicion of tumor recurrence. Redo reconstruction is feasible in selected patients.

Indexed as

Late venous stenosisReconstructed hepatic veinRedo reconstructionTumor recurrenceVenous stenosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.